Early Treatment with Poly(ADP-Ribose) Polymerase-1 Inhibitor (JPI-289) Reduces Infarct Volume and Improves Long-Term Behavior in an Animal Model of Ischemic Stroke
出版年份 2018 全文链接
标题
Early Treatment with Poly(ADP-Ribose) Polymerase-1 Inhibitor (JPI-289) Reduces Infarct Volume and Improves Long-Term Behavior in an Animal Model of Ischemic Stroke
作者
关键词
Ischemic stroke, PARP-1, JPI-289, Neuroprotection
出版物
MOLECULAR NEUROBIOLOGY
Volume -, Issue -, Pages -
出版商
Springer Nature
发表日期
2018-01-30
DOI
10.1007/s12035-018-0910-6
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Reconsidering Neuroprotection in the Reperfusion Era
- (2017) Sean I. Savitz et al. STROKE
- Phase I and Phase II Therapies for Acute Ischemic Stroke: An Update on Currently Studied Drugs in Clinical Research
- (2017) Cesar Reis et al. Biomed Research International
- Strategies to Extend Thrombolytic Time Window for Ischemic Stroke Treatment: An Unmet Clinical Need
- (2017) Ike dela Peña et al. Journal of Stroke
- Early Activation of Phosphatidylinositol 3-Kinase after Ischemic Stroke Reduces Infarct Volume and Improves Long-Term Behavior
- (2016) Young Seo Kim et al. MOLECULAR NEUROBIOLOGY
- Neuroprotective Effects of Poly(ADP-ribose)polymerase Inhibitor Olaparib in Transient Cerebral Ischemia
- (2016) Fei Teng et al. NEUROCHEMICAL RESEARCH
- Discovery of 1-substituted benzyl-quinazoline-2,4(1H,3H)-dione derivatives as novel poly(ADP-ribose)polymerase-1 inhibitors
- (2015) Haiping Yao et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Poly(ADP-ribose) Polymerase-1 Inhibition in Brain Endothelium Protects the Blood—Brain Barrier under Physiologic and Neuroinflammatory Conditions
- (2014) Slava Rom et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Discovery and Structure–Activity Relationship of Novel 2,3-Dihydrobenzofuran-7-carboxamide and 2,3-Dihydrobenzofuran-3(2H)-one-7-carboxamide Derivatives as Poly(ADP-ribose)polymerase-1 Inhibitors
- (2014) Maulik R. Patel et al. JOURNAL OF MEDICINAL CHEMISTRY
- Parthanatos: mitochondrial-linked mechanisms and therapeutic opportunities
- (2013) Amos A Fatokun et al. BRITISH JOURNAL OF PHARMACOLOGY
- Regulatory T Cell in Stroke: A New Paradigm for Immune Regulation
- (2013) Sheng Chen et al. Clinical & Developmental Immunology
- Prevention of rt-PA induced blood–brain barrier component degradation by the poly(ADP-ribose)polymerase inhibitor PJ34 after ischemic stroke in mice
- (2013) Fei Teng et al. EXPERIMENTAL NEUROLOGY
- Beyond DNA repair, the immunological role of PARP-1 and its siblings
- (2013) Maria Manuela Rosado et al. IMMUNOLOGY
- Combined therapy with PJ34, a poly(ADP-ribose)polymerase inhibitor, reduces tissue plasminogen activator-induced hemorrhagic transformations in cerebral ischemia in mice
- (2012) Marianne Haddad et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis
- (2012) Joanna M Wardlaw et al. LANCET
- Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
- (2012) Christopher J L Murray et al. LANCET
- Poly (ADP-Ribose) Polymerase-1 (PARP-1) as Immune Regulator
- (2012) Federica Laudisi et al. Endocrine Metabolic & Immune Disorders-Drug Targets
- Neuroprotective effects of a novel water-soluble poly(ADP-ribose) polymerase-1 inhibitor, MP-124, in in vitro and in vivo models of cerebral ischemia
- (2011) Yasuhiro Egi et al. BRAIN RESEARCH
- Long-lasting neuroprotection and neurological improvement in stroke models with new, potent and brain permeable inhibitors of poly(ADP-ribose) polymerase
- (2011) F Moroni et al. BRITISH JOURNAL OF PHARMACOLOGY
- Sex Differences in the Response to Poly(ADP-ribose) Polymerase-1 Deletion and Caspase Inhibition After Stroke
- (2011) Fudong Liu et al. STROKE
- Poly(ADP-Ribose) Metabolism in Brain and Its Role in Ischemia Pathology
- (2010) Robert Piotr Strosznajder et al. MOLECULAR NEUROBIOLOGY
- Sex differences in the response to activation of the poly (ADP-ribose) polymerase pathway after experimental stroke
- (2009) Mike Yuan et al. EXPERIMENTAL NEUROLOGY
- Update of the Stroke Therapy Academic Industry Roundtable Preclinical Recommendations
- (2009) Marc Fisher et al. STROKE
- Inhibition of GSK-3 reduces infarct volume and improves neurobehavioral functions
- (2008) Seong-Ho Koh et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Post-ischemic brain damage: targeting PARP-1 within the ischemic neurovascular units as a realistic avenue to stroke treatment
- (2008) Flavio Moroni et al. FEBS Journal
- Poly(ADP-ribose)polymerase 1 (PARP-1) and postischemic brain damage
- (2007) F MORONI CURRENT OPINION IN PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search